Substance Use Disorder Linked to Increased Risk for COVID-19
Increased risk especially strong for those with opioid use disorder, tobacco use disorder.
Infectious Disease
Vaccine Campaign Would Take 6 to 9 Months to Curb COVID-19
First to be vaccinated would be those with health conditions that make them vulnerable to severe illness, death.
Factor V Activity Significantly Increased in Severe COVID-19
Rates of DVT/PE significantly higher for patients with COVID-19 and elevated factor V activity.
Risk of Cardiac Events With Azithromycin, Amoxicillin Compared
The aim of the study was to use real-world data to compare the risk of cardiac events in new users of azithromycin vs amoxicillin.
Baricitinib Plus Remdesivir Cuts Time to Recovery for Hospitalized COVID-19 Patients
The ACTT-2 study began on May 8 and included more than 1000 patients.
NIH Launches Clinical Trials of Antithrombotics for COVID-19
Adaptive design allows evaluation of various doses, types of blood thinners in outpatients, inpatients.
Widespread Avoidance of Medical Care Found Due to COVID-19 Concerns
Prevalence of care avoidance higher for caregivers, those with underlying conditions, disabilities.
As Tough COVID-19 Summer Ends, Experts Warn of Tougher Fall, Winter
A cold-weather surge of COVID-19 cases could trigger a much-feared ‘second wave’ of infections and deaths.
AstraZeneca Pauses COVID-19 Vaccine Trials
In a statement, the Company noted that the actions being taken are considered “routine” when an unexplained illness is reported in a clinical trial.
Trial Evaluating Half-Life Extended Monoclonal Antibodies for COVID-19 Begins
The trial will include up to 48 healthy participants in the UK.
-
Loading...
-
Loading...
Next post in Men's Health Update
